| Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients (NCT05252078) | Jiangxi Provincial Cancer Hospital | 2022-06-02 |
| Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer (NCT05349045) | The First Affiliated Hospital of Zhengzhou University | 2022-05-05 |
| Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer (NCT03153280) | Cancer Trials Ireland | 2022-01-13 |
| TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer. (NCT05013697) | Henan Cancer Hospital | 2021-09-01 |
| A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer (NCT04945733) | Janssen Pharmaceutical K.K. | 2021-08-30 |
| PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma (NCT05007145) | Fujian Cancer Hospital | 2021-08-15 |
| Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China (NCT05194371) | Chinese Academy of Medical Sciences | 2021-06-01 |
| Thromboprophylaxis in Oesophageal Cancer Patients (NCT05067153) | University of Aarhus | 2021-05-01 |
| Endoscopic Resection of Gastrointestinal Neoplasms (NCT04780256) | Azienda USL Reggio Emilia - IRCCS | 2021-03-15 |
| A Study of SGN-STNV in Advanced Solid Tumors (NCT04665921) | Seagen Inc. | 2021-01-18 |
| Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer (NCT05800054) | The First Affiliated Hospital with Nanjing Medical University | 2021-01-01 |
| Prevalence of Sub-epithelial Lesions Among Patients Undergoing EGDs in Egypt (NCT04622098) | Kafrelsheikh University | 2020-11-18 |
| Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy (NCT04513418) | Hecheng Li M.D., Ph.D | 2020-11-10 |
| Tissue Oxygen Saturation for Esophagectomy (NCT04973046) | Shizuoka Cancer Center | 2020-11-01 |
| A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection (NCT04510285) | Memorial Sloan Kettering Cancer Center | 2020-08-10 |
| Non-curative ESDs: Assessing the Rates and Risk Factors for Residual Neoplasia (NCT04484311) | Universidade do Porto | 2020-08-01 |
| Health and Employment After Gastro Intestinal Surgery - HEAGIS2 (NCT04466631) | University of Padova | 2020-06-15 |
| Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC) (NCT04654975) | Universitaire Ziekenhuizen KU Leuven | 2020-06-02 |
| Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI (NCT04359732) | IRCCS San Raffaele | 2020-05-08 |
| Mediastinoscopy-assisted Transhiatal Esophagectomy Versus Thoraco-laparoscopic Esophagectomy for Esophageal Cancer (NCT04125849) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2020-04-01 |
| Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery (NCT04189393) | Radboud University Medical Center | 2020-01-01 |
| Health and Employment After Gastro Intestinal Surgery - HEAGIS1 (NCT04466592) | University of Padova | 2019-12-13 |
| Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases (NCT02859415) | National Cancer Institute (NCI) | 2019-08-08 |
| Automatic Diagnosis of Early Esophageal Squamous Neoplasia Using pCLE With AI (NCT04136236) | Shandong University | 2019-08-01 |
| TreatmENT of AnastomotiC Leakage After Esophagectomy (NCT03829098) | Radboud University Medical Center | 2019-04-01 |
| Distribution of Lymph Node Metastases in Esophageal Carcinoma (NCT03222895) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2019-03-01 |
| First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension Study (NCT03881111) | Merck Sharp & Dohme LLC | 2019-01-21 |
| A Study of Second-line Treatment of Postoperative Recurrence and Metastasis of Esophageal Cancer Treated With Apatinib (NCT03787251) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2019-01-01 |
| Anlotinib Retrospective Study for Esophageal Cancer (NCT05303740) | Feng Wang | 2019-01-01 |
| The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage I (NCT02845479) | The Canadian College of Naturopathic Medicine | 2018-12-07 |
| Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction (NCT03549494) | Catalysis SL | 2018-10-25 |
| OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma (NCT03429816) | University Hospital Heidelberg | 2018-04-15 |
| Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer (NCT03474341) | UMC Utrecht | 2018-04-09 |
| Feasibility of Multi-Spectral Endoscopic Imaging for Detection of Early Neoplasia in Barrett's Oesophagus (NCT03388047) | University of Cambridge | 2018-01-01 |
| Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02 (NCT03308552) | Chinese Academy of Medical Sciences | 2017-12-01 |
| Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy (NCT03223662) | National Cancer Institute (NCI) | 2017-10-31 |
| A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors (NCT03261947) | Millennium Pharmaceuticals, Inc. | 2017-10-25 |
| Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell Carcinoma (NCT03200691) | Hangzhou Cancer Hospital | 2017-08-10 |
| First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590) (NCT03189719) | Merck Sharp & Dohme LLC | 2017-07-25 |
| Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer (NCT03579004) | Mona Frolova | 2017-07-10 |
| Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (NCT03274011) | Fudan University | 2017-07-01 |
| Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer (NCT03187314) | Hangzhou Cancer Hospital | 2017-06-14 |
| Endoscopic Resection Multicenter Registry (NCT03065257) | Weill Medical College of Cornell University | 2017-03-15 |
| Gravity Assisted Technique for Esophageal Endoscopic Submucosal Dissection (ESD) (NCT04547881) | Baylor College of Medicine | 2016-12-12 |
| Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer (NCT03011255) | Shixiu Wu | 2016-12-01 |
| Early Detection of Esophageal Cancer (NCT00341523) | National Cancer Institute (NCI) | 2016-11-01 |
| Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma (NCT02908204) | Shanghai Zhongshan Hospital | 2016-10-01 |
| A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC (NCT02721550) | Shandong Cancer Hospital and Institute | 2016-08-01 |
| Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer (NCT03254511) | Mashhad University of Medical Sciences | 2016-07-22 |
| A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC (NCT02721576) | Shandong Cancer Hospital and Institute | 2016-07-05 |
| Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based Biomarkers (NCT05688176) | University Hospital, Ghent | 2016-06-01 |
| Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma (NCT02858206) | Chinese Academy of Medical Sciences | 2016-06-01 |
| Tumor Hypoxia With HX4 PET in Several Diseases (NCT02584400) | Maastricht Radiation Oncology | 2016-05-01 |
| A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC (NCT02721563) | Shandong Cancer Hospital and Institute | 2016-02-25 |
| Influence of Esophageal Washout on Local Carcinoma Recurrence After Curative Resection (NCT02676791) | Technische Universität Dresden | 2016-02-16 |
| Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer (NCT02891083) | Shanghai Chest Hospital | 2016-01-01 |
| Analysis of Risk Factors of Postoperative Pulmonary Infection in Patients With Esophageal Cancer (NCT05740852) | Xijing Hospital | 2016-01-01 |
| Comparison of Captivator Tissue Cassettes vs. no Cassettes for Endoscopic Mucosal Resection in Esophageal Carcinoma (NCT02911363) | AdventHealth | 2016-01-01 |
| Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer (NCT02644863) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2015-12-01 |
| Nutritional Route In Esophageal Resection Trial II (NCT02378948) | Catharina Ziekenhuis Eindhoven | 2015-10-01 |
| Endoscopic Evaluation After Esophagectomy (NCT02703142) | Nagasaki University | 2015-10-01 |
| Mayo Clinic Upper Digestive Disease Survey (NCT02530983) | Mayo Clinic | 2015-08-15 |
| Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal Cancer (NCT02937519) | Guiyang Medical University | 2015-06-01 |
| Endoscopic Evaluation for Predicting the Complications Related to Gastric Conduit After Esophagectomy (NCT02937389) | Nagasaki University | 2015-05-01 |
| Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma (NCT02406170) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2015-04-01 |
| Impact of Perioperative Physical Activity on Postoperative Pulmonary Complications and Quality of Life Among Esophageal Cancer Patients (NCT03231462) | Samsung Medical Center | 2015-03-06 |
| Feasibility Study of Fiducial Markers in Oesophageal Cancer (NCT02403050) | NHS Greater Glasgow and Clyde | 2015-03-01 |
| The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery (NCT02381249) | St. James's Hospital, Ireland | 2015-03-01 |
| Longitudinal Assessment of Gut Hormone Secretion Following Upper Gastrointestinal Surgery for Cancer (NCT02385630) | St. James's Hospital, Ireland | 2015-03-01 |
| PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer (NCT02359968) | Centre Oscar Lambret | 2015-02-26 |
| Endoscopic Injection of Mitomycin C for the Treatment of Pharyngoesophageal Stenosis (NCT03540953) | Fauze Maluf Filho | 2015-01-05 |
| Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms (NCT02430701) | Fuda Cancer Hospital, Guangzhou | 2015-01-01 |
| Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma (NCT02429622) | Chinese Academy of Medical Sciences | 2015-01-01 |
| Cardiopulmonary Effects of Intrathoracic Pressure Overshoot During Carbon Dioxide Insufflation in Thoracoscopic Surgery (NCT02330536) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2014-12-01 |
| Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial (NCT02319187) | Chinese Academy of Medical Sciences | 2014-12-01 |
| The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy (NCT02604615) | The First Affiliated Hospital of Henan University of Science and Technology | 2014-10-01 |
| Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma (NCT02279134) | Zefen Xiao | 2014-10-01 |
| Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy (NCT02284802) | Fauze Maluf Filho | 2014-09-10 |
| Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer (NCT02128243) | AIO-Studien-gGmbH | 2014-09-01 |
| Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal Cancer (NCT02253602) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2014-09-01 |
| Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma (NCT02177552) | Rigshospitalet, Denmark | 2014-06-01 |
| A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab (NCT02013154) | Leap Therapeutics, Inc. | 2014-05-05 |
| Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer (NCT02017002) | National Taiwan University Hospital | 2014-03-01 |
| Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer (NCT02305043) | University of Leipzig | 2014-03-01 |
| The Predictive Value of CT-PET in Esophageal Cancer (NCT02385604) | St. James's Hospital, Ireland | 2014-01-01 |
| Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer (NCT02030769) | Xijing Hospital of Digestive Diseases | 2014-01-01 |
| Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer (NCT02385617) | St. James's Hospital, Ireland | 2014-01-01 |
| Effect of Neck Flexion on Esophagogastric Anastomotic Leakage After MIE (NCT02418052) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2014-01-01 |
| Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer (NCT01928290) | Washington University School of Medicine | 2013-11-08 |
| Removal of the Evolution® Esophageal Stent - Fully Covered (NCT01900691) | Cook Group Incorporated | 2013-09-01 |
| Esophagectomy:Three-field Versus Two-field Lymphadenectomy (ECTOP-2002) (NCT01807936) | Fudan University | 2013-03-20 |
| A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer (NCT02182804) | King Chulalongkorn Memorial Hospital | 2013-02-01 |
| Radiation Dose Study of Concurrent Chemoradiotherapy With Cisplatin Plus Fluorouracil in Oesophageal Cancer (NCT01646853) | Simcere Pharmaceutical Co., Ltd | 2012-08-01 |
| Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer (NCT01670409) | Chuangzhen Chen | 2012-08-01 |
| Home Jejunostomy Feeding Following Esophagectomy/Gastrectomy (NCT01870817) | University Hospitals, Leicester | 2012-07-01 |
| Impact of Gastric Tube Reconstruction Widths on Quality of Life for Esophagogastric Cancers (NCT01911832) | West China Hospital | 2012-03-01 |
| Docetaxel and S-1 for Advanced Esophageal Cancer (NCT01693432) | Hallym University Medical Center | 2011-11-01 |
| Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus (NCT01572987) | Midwest Biomedical Research | 2011-09-01 |
| Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma (NCT00504322) | Weill Medical College of Cornell University | 2011-07-01 |
| The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery (NCT01267305) | Shanghai Zhongshan Hospital | 2011-01-01 |